Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Increases By 165.7%

Nanovibronix, Inc. (NASDAQ:FEED) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 161,665 shares, a growth of 165.7% from the June 30th total of 60,839 shares. Based on an average daily trading volume, of 507,400 shares, the short-interest ratio is currently 0.3 days. Approximately 2.7% of the company’s stock are short sold.

Nanovibronix Trading Down 1.4%

Shares of NASDAQ FEED traded down $0.00 during midday trading on Wednesday, reaching $0.34. 21,117 shares of the company traded hands, compared to its average volume of 5,851,404. The firm has a market capitalization of $2.06 million, a P/E ratio of -0.04 and a beta of 1.56. The stock’s 50-day moving average is $0.66. Nanovibronix has a 52 week low of $0.33 and a 52 week high of $17.40.

Nanovibronix (NASDAQ:FEED) last released its earnings results on Monday, May 18th. The company reported ($6.88) EPS for the quarter. The company had revenue of $0.65 million for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%.

Insider Buying and Selling

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The sale was disclosed in a document filed with the SEC, which is available at this link. 5.20% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research note on Tuesday, July 21st. Wall Street Zen upgraded shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a research report on Sunday, July 12th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.